Evidence map›Paper›PMID 39834434›Full record

ArticleHeliyon2025

The feasibility study of transfer arc plasma pyrolysis system for petrochemical wastes: Hydrogen production from Antar, OTD, and Tar.

Amir Hossein Kheyriyeh, Farzaneh Ostovarpour, Mohammadreza Khani, Mohammad Sadegh Abbassi Shanbehbazari, Babak Shokri

Abstract read
In one paragraph

Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amir Hossein KheyriyehLaser and Plasma Research Institute, Shahid Beheshti, University, G.C., Evin, 19839-63113, Tehran, Iran.
Farzaneh OstovarpourLaser and Plasma Research Institute, Shahid Beheshti, University, G.C., Evin, 19839-63113, Tehran, Iran.
Mohammadreza KhaniLaser and Plasma Research Institute, Shahid Beheshti, University, G.C., Evin, 19839-63113, Tehran, Iran.
Mohammad Sadegh Abbassi ShanbehbazariLaser and Plasma Research Institute, Shahid Beheshti, University, G.C., Evin, 19839-63113, Tehran, Iran.
Babak ShokriLaser and Plasma Research Institute, Shahid Beheshti, University, G.C., Evin, 19839-63113, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the best and most advanced methods for disposal of urban, hospital, industrial, and other hazardous waste is to convert waste into combustible gases in reactors based on plasma arc technology. Also used for renewable energy generation, this technology involves thermal treatment without a combustion process; therefore, the waste is completely decomposed into simple molecules in a near vacuum environment almost devoid of Oxygen at elevated temperatures. The present research uses a thermal transferred arc plasma reactor to conduct a feasibility study on the pyrolysis of three types of wastes: Antar, Orthotoluenediamine (OTD), and Tar. To this end, three experiments were conducted, and the effective parameters involved in preparing and producing common gaseous raw materials and products, such as hydrogen, and their production amounts were examined. The outcome demonstrates that there are no remnants of spent catalyst waste following the plasma pyrolysis process, confirming the feasibility of complete conversion. The findings of this study revealed that plasma waste reactors could generate recycled energy in the form of renewable fuel free of toxic gases and vapors released from conventional waste incinerators and create negligible amounts of environmental pollutants.

Indexed as

Hydrogen productionPetrochemical wastePlasma pyrolysisThermal plasma

Identifiers

PMID39834434
PMCPMC11745793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.